InsiderClue

Every filing, one decision per row.

Transactions

One row for every decision an insider filed. Open-market buying and selling only. Vesting, grants and the shares withheld to pay the tax on them are not decisions.

Views

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

Create an account Sign in
Companies 1/25
KPTI
Result 348 decisions over 120 months
Reset filters
Direction ?
Both348 Bought4 Sold344
Sort by ?
Most recent Largest amount Share of holding
Window ?
1 mo 12 mo 120 mo
Plan ?
Any Discretionary Scheduled (10b5-1) Not stated
Minimum amount ?
Any $100K $1M $10M $100M $500M
Share of their own holding ?
What the chief executive holds ?
Company: KPTI
Company
Date
Insider
Role
Action ?
Shares
Amount
Of holding
KPTI Karyopharm Therapeutics Inc.
8 Apr 2020
Shacham Sharon
President & CSO
Sold, plan not stated
10,000
$186.12K
1.3%
KPTI Karyopharm Therapeutics Inc.
10 Mar 2020
Shacham Sharon
President & CSO indirect
Sold, plan not stated 2×
10,000
$222.19K
1.8%
KPTI Karyopharm Therapeutics Inc.
10 Mar 2020
Kauffman Michael
Chief Executive Officer
Sold, plan not stated 2×
10,000
$222.19K
1.8%
KPTI Karyopharm Therapeutics Inc.
9 Mar 2020
Shacham Sharon
President & CSO
Sold, plan not stated 2×
10,000
$225.19K
1.3%
KPTI Karyopharm Therapeutics Inc.
9 Mar 2020
Kauffman Michael
Chief Executive Officer indirect
Sold, plan not stated 2×
10,000
$225.19K
1.3%
KPTI Karyopharm Therapeutics Inc.
2 Mar 2020
Primiano Christopher Brett
EVP, CBO, GC & Secretary
Sold, plan not stated 3×
26,500
$672.28K
71.9%
KPTI Karyopharm Therapeutics Inc.
2 Mar 2020
Mirza Mansoor Raza
Director
Sold, plan not stated
5,000
$117.50K
100%
KPTI Karyopharm Therapeutics Inc.
19 Feb 2020
Shacham Sharon
President & CSO
Sold, plan not stated
8,817
$145.32K
1.2%
KPTI Karyopharm Therapeutics Inc.
19 Feb 2020
Shacham Sharon
President & CSO indirect
Sold, plan not stated
8,817
$145.32K
1.6%
KPTI Karyopharm Therapeutics Inc.
19 Feb 2020
Kauffman Michael
Chief Executive Officer
Sold, plan not stated
8,817
$145.32K
1.6%
KPTI Karyopharm Therapeutics Inc.
19 Feb 2020
Kauffman Michael
Chief Executive Officer indirect
Sold, plan not stated
8,817
$145.32K
1.2%
KPTI Karyopharm Therapeutics Inc.
19 Feb 2020
Frenkel Ran
Chief Dev Operations Officer
Sold, plan not stated
2,975
$49.03K
7.6%
KPTI Karyopharm Therapeutics Inc.
19 Feb 2020
Primiano Christopher Brett
EVP, CBO, GC & Secretary
Sold, plan not stated
2,961
$48.80K
22.2%
KPTI Karyopharm Therapeutics Inc.
19 Feb 2020
Shah Jatin
EVP, Chief Medical Officer
Sold, plan not stated
1,375
$22.66K
3.3%
KPTI Karyopharm Therapeutics Inc.
11 Feb 2020
Shacham Sharon
President & CSO indirect
Sold, plan not stated
10,000
$174.29K
1.8%
KPTI Karyopharm Therapeutics Inc.
11 Feb 2020
Kauffman Michael
Chief Executive Officer
Sold, plan not stated
10,000
$174.29K
1.8%
KPTI Karyopharm Therapeutics Inc.
10 Feb 2020
Shacham Sharon
President & CSO
Sold, plan not stated
10,000
$169.33K
1.3%
KPTI Karyopharm Therapeutics Inc.
10 Feb 2020
Kauffman Michael
Chief Executive Officer indirect
Sold, plan not stated
10,000
$169.33K
1.3%
KPTI Karyopharm Therapeutics Inc.
9 Jan 2020
Kauffman Michael
Chief Executive Officer
Sold, plan not stated
10,000
$191.88K
1.8%
KPTI Karyopharm Therapeutics Inc.
9 Jan 2020
Shacham Sharon
President & CSO indirect
Sold, plan not stated
10,000
$191.88K
1.8%
KPTI Karyopharm Therapeutics Inc.
9 Jan 2020
Mirza Mansoor Raza
Director
Sold, plan not stated
2,056
$41.12K
100%
KPTI Karyopharm Therapeutics Inc.
8 Jan 2020
Kauffman Michael
Chief Executive Officer indirect
Sold, plan not stated
10,000
$185.71K
1.3%
KPTI Karyopharm Therapeutics Inc.
8 Jan 2020
Shacham Sharon
President & CSO
Sold, plan not stated
10,000
$185.71K
1.3%
KPTI Karyopharm Therapeutics Inc.
27 Dec 2019
Primiano Christopher Brett
EVP, CBO, GC & Secretary
Sold, plan not stated
5,000
$100.00K
57.8%
KPTI Karyopharm Therapeutics Inc.
27 Dec 2019
Mirza Mansoor Raza
Director
Sold, plan not stated
2,944
$58.88K
100%
KPTI Karyopharm Therapeutics Inc.
18 Dec 2019
Mirza Mansoor Raza
Director indirect
Sold, plan not stated 2×
12,121
$208.24K
100%
KPTI Karyopharm Therapeutics Inc.
10 Dec 2019
Kauffman Michael
Chief Executive Officer
Sold, plan not stated
10,000
$159.90K
1.9%
KPTI Karyopharm Therapeutics Inc.
10 Dec 2019
Shacham Sharon
President & CSO indirect
Sold, plan not stated
10,000
$159.90K
1.9%
KPTI Karyopharm Therapeutics Inc.
9 Dec 2019
Mirza Mansoor Raza
Director
Sold, plan not stated 2×
10,342
$176.03K
100%
KPTI Karyopharm Therapeutics Inc.
9 Dec 2019
Kauffman Michael
Chief Executive Officer indirect
Sold, plan not stated
10,000
$170.21K
1.3%
KPTI Karyopharm Therapeutics Inc.
9 Dec 2019
Shacham Sharon
President & CSO
Sold, plan not stated
10,000
$170.21K
1.3%
KPTI Karyopharm Therapeutics Inc.
6 Dec 2019
Primiano Christopher Brett
EVP, CBO, GC & Secretary
Sold, plan not stated 3×
13,000
$226.91K
78.1%
KPTI Karyopharm Therapeutics Inc.
11 Nov 2019
Kauffman Michael
Chief Executive Officer
Sold, plan not stated
10,000
$147.61K
1.9%
KPTI Karyopharm Therapeutics Inc.
11 Nov 2019
Shacham Sharon
President & CSO indirect
Sold, plan not stated
10,000
$147.61K
1.9%
KPTI Karyopharm Therapeutics Inc.
8 Nov 2019
Kauffman Michael
Chief Executive Officer indirect
Sold, plan not stated
10,000
$146.25K
1.3%
KPTI Karyopharm Therapeutics Inc.
8 Nov 2019
Shacham Sharon
President & CSO
Sold, plan not stated
10,000
$146.25K
1.3%
KPTI Karyopharm Therapeutics Inc.
1 Nov 2019
Shacham Sharon
President & CSO
Sold, plan not stated
10,000
$120.00K
1.3%
KPTI Karyopharm Therapeutics Inc.
1 Nov 2019
Shacham Sharon
President & CSO indirect
Sold, plan not stated
10,000
$120.00K
1.9%
KPTI Karyopharm Therapeutics Inc.
1 Nov 2019
Kauffman Michael
Chief Executive Officer
Sold, plan not stated
10,000
$120.00K
1.9%
KPTI Karyopharm Therapeutics Inc.
1 Nov 2019
Kauffman Michael
Chief Executive Officer indirect
Sold, plan not stated
10,000
$120.00K
1.3%
KPTI Karyopharm Therapeutics Inc.
16 Sep 2019
Kauffman Michael
Chief Executive Officer
Sold, plan not stated
10,000
$120.00K
1.9%
KPTI Karyopharm Therapeutics Inc.
16 Sep 2019
Kauffman Michael
Chief Executive Officer indirect
Sold, plan not stated
10,000
$120.00K
1.3%
KPTI Karyopharm Therapeutics Inc.
16 Sep 2019
Shacham Sharon
President & CSO
Sold, plan not stated
10,000
$120.00K
1.3%
KPTI Karyopharm Therapeutics Inc.
16 Sep 2019
Shacham Sharon
President & CSO indirect
Sold, plan not stated
10,000
$120.00K
1.9%
KPTI Karyopharm Therapeutics Inc.
28 Feb 2019
Chione Ltd
10% owner
Sold, plan not stated
149,624
$619.11K
2.4%
KPTI Karyopharm Therapeutics Inc.
27 Feb 2019
Chione Ltd
10% owner
Sold, plan not stated
558,243
$2.52M
8.3%
KPTI Karyopharm Therapeutics Inc.
26 Feb 2019
Chione Ltd
10% owner
Sold, plan not stated
123,400
$617.21K
1.8%
KPTI Karyopharm Therapeutics Inc.
25 Feb 2019
Chione Ltd
10% owner
Sold, plan not stated
800,000
$3.99M
10.5%
KPTI Karyopharm Therapeutics Inc.
7 Jan 2019
Kauffman Michael
Chief Executive Officer indirect
Sold, plan not stated
12,500
$127.82K
1.7%
KPTI Karyopharm Therapeutics Inc.
7 Jan 2019
Shacham Sharon
President & CSO
Sold, plan not stated
12,500
$127.82K
1.7%
Showing 201–250 of 348. ← Newer Page 5 of 7 Older →